GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Alibaba Health Information Technology Ltd (HKSE:00241) » Definitions » Total Revenue Growth Rate (Future 3Y To 5Y Est)

Alibaba Health Information Technology (HKSE:00241) Total Revenue Growth Rate (Future 3Y To 5Y Est) : 9.76 (As of May. 02, 2024)


View and export this data going back to 1972. Start your Free Trial

What is Alibaba Health Information Technology Total Revenue Growth Rate (Future 3Y To 5Y Est)?

Total Revenue Growth Rate (Future 3Y To 5Y Est) is the average growth rate of total revenue estimates over a 3-year to 5-year period.

As of today, Alibaba Health Information Technology's Total Revenue Growth Rate (Future 3Y To 5Y Est) is 9.76.


Competitive Comparison of Alibaba Health Information Technology's Total Revenue Growth Rate (Future 3Y To 5Y Est)

For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's Total Revenue Growth Rate (Future 3Y To 5Y Est), along with its competitors' market caps and Total Revenue Growth Rate (Future 3Y To 5Y Est) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alibaba Health Information Technology's Total Revenue Growth Rate (Future 3Y To 5Y Est) Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's Total Revenue Growth Rate (Future 3Y To 5Y Est) distribution charts can be found below:

* The bar in red indicates where Alibaba Health Information Technology's Total Revenue Growth Rate (Future 3Y To 5Y Est) falls into.



Alibaba Health Information Technology  (HKSE:00241) Total Revenue Growth Rate (Future 3Y To 5Y Est) Explanation

Total Revenue Growth Rate (Future 3Y To 5Y Est) is the growth rate of total revenue estimates over a 3-year to 5-year period. This data is provided directly by our trusted data vendors Refinitiv or Morningstar.

In situations where both vendors do not directly provide the growth rate data, we use the most recent annual revenue for the current year and estimated future revenue figures provided by the vendor to calculate the growth rate. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average total revenue estimates growth rate.


Alibaba Health Information Technology Total Revenue Growth Rate (Future 3Y To 5Y Est) Related Terms

Thank you for viewing the detailed overview of Alibaba Health Information Technology's Total Revenue Growth Rate (Future 3Y To 5Y Est) provided by GuruFocus.com. Please click on the following links to see related term pages.


Alibaba Health Information Technology (HKSE:00241) Business Description

Traded in Other Exchanges
Address
Guanghua Road, 65/F, CITIC Tower, Building 1, No.10, Jianwai Subdistrict, Chaoyang District, Beijing, CHN
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or "Dr. Deer", although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 97% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.

Alibaba Health Information Technology (HKSE:00241) Headlines

No Headlines